Current Ratio of Moleculin Biotech, Inc. from 31 Mar 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Moleculin Biotech, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2017 to 30 Sep 2025.
  • Moleculin Biotech, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 122%, a 59% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Moleculin Biotech, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 122% -178% -59% 30 Sep 2025
Q2 2025 137% -259% -65% 30 Jun 2025
Q1 2025 169% -308% -65% 31 Mar 2025
Q4 2024 224% -353% -61% 31 Dec 2024
Q3 2024 299% -429% -59% 30 Sep 2024
Q2 2024 396% -367% -48% 30 Jun 2024
Q1 2024 477% -427% -47% 31 Mar 2024
Q4 2023 577% -464% -45% 31 Dec 2023
Q3 2023 729% -503% -41% 30 Sep 2023
Q2 2023 763% -785% -51% 30 Jun 2023
Q1 2023 905% -1027% -53% 31 Mar 2023
Q4 2022 1041% -1060% -50% 31 Dec 2022
Q3 2022 1231% -590% -32% 30 Sep 2022
Q2 2022 1548% +132% +9.3% 30 Jun 2022
Q1 2022 1932% +976% +102% 31 Mar 2022
Q4 2021 2101% +1606% +324% 31 Dec 2021
Q3 2021 1821% +1376% +309% 30 Sep 2021
Q2 2021 1416% +1113% +368% 30 Jun 2021
Q1 2021 955% +715% +298% 31 Mar 2021
Q4 2020 495% +293% +146% 31 Dec 2020
Q3 2020 445% +264% +145% 30 Sep 2020
Q2 2020 303% +98% +48% 30 Jun 2020
Q1 2020 240% +13% +5.8% 31 Mar 2020
Q4 2019 201% -139% -41% 31 Dec 2019
Q3 2019 182% -212% -54% 30 Sep 2019
Q2 2019 205% -241% -54% 30 Jun 2019
Q1 2019 227% -315% -58% 31 Mar 2019
Q4 2018 340% -118% -26% 31 Dec 2018
Q3 2018 393% -77% -16% 30 Sep 2018
Q2 2018 446% -18% -3.9% 30 Jun 2018
Q1 2018 542% +87% +19% 31 Mar 2018
Q4 2017 458% 31 Dec 2017
Q3 2017 470% 30 Sep 2017
Q2 2017 464% 30 Jun 2017
Q1 2017 455% 31 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.